AlphaGrep UK Ltd’s Hologic HOLX Stock Holding History

AlphaGrep UK Ltd’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,032	Closed	-$524K	–	853
2025 Q4	$524K	Buy	+7,032	New	+$514K	0.17%	198

Other funds holding HOLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AlphaGrep UK Ltd's HOLX Position: Q1 2026 in Review

AlphaGrep UK Ltd sold out of Hologic (HOLX) in Q1 2026, closing a stake of 7,032 shares — an estimated $524K sold.

AlphaGrep UK Ltd first reported a position in HOLX in Q4 2025 and held it in 1 quarter. The position peaked at $524K in Q4 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

AlphaGrep UK Ltd reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
AlphaGrep UK Ltd sold 7,032 Hologic shares in Q1 2026, an estimated $524K.
AlphaGrep UK Ltd first reported a position in Hologic in Q4 2025 and held it in 1 quarter.
AlphaGrep UK Ltd's Hologic position peaked at $524K in Q4 2025.
704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.